India Exchange Filings

Orchid Pharma Q2 FY27 Board Meeting Highlights

Orchid Pharma Ltd approves Q2 and H1 FY27 results, with Q2 revenue up 14.4% YoY to ₹341.27 crore

  • Standalone Q2 net profit was ₹36.76 crore, up 432.1% YoY.
  • Consolidated Q2 net profit was ₹28.59 crore, versus a ₹0.90 crore loss a year earlier.
  • Auditors issued unmodified review conclusions; certain subsidiary and associate financial information was not reviewed by the principal auditor.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.